Status:
COMPLETED
Evaluation of a Mobile App to Promote Social Support for Oncology Patients
Lead Sponsor:
West Cancer Center
Collaborating Sponsors:
Pfizer
Emory University
Conditions:
Chemotherapy Effect
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our study will evaluate patient and caregiver use of a new mobile application (app) to support patients undergoing chemotherapy treatment for cancer.
Detailed Description
The app is designed to be used by the patient and members of their support network. It provides wide-ranging functionality, including: reminders for appointments and tasks, the ability to track health...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Patients must have a confirmed diagnosis of cancer and be prior to or within one month of initiating chemotherapy or immunotherapy
- Have a valid email address
- Have a smart mobile device (Android or iOS) with a data plan
- Willing to download and use the study app
Exclusion
- Unable to communicate in English.
Key Trial Info
Start Date :
March 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 24 2021
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04331678
Start Date
March 12 2020
End Date
October 24 2021
Last Update
December 18 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
West Cancer Center
Southaven, Mississippi, United States, 38671
2
West Cancer Center
Germantown, Tennessee, United States, 38138
3
West Cancer Center
Memphis, Tennessee, United States, 38104